Stange Sebastian, Sziklavari Zsolt
Klinik für Thoraxchirurgie, REGIOMED Kliniken GmbH, Sonneberg/Coburg, Deutschland.
Zentralbl Chir. 2019 Jun;144(3):290-297. doi: 10.1055/a-0733-7268. Epub 2018 Oct 15.
Chylothorax is a multifactorial complication, usually caused by surgery or traumatic injury, and more rarely by malignant disease. Because of the lack of prospective, randomised trials, the evidence-based treatment rests upon personal experience, but ideally taking into account retrospective analysis.
The aim of this review is to provide a comprehensive overview of the currently available modern treatment options. Another aspect is to show their advantages and disadvantages. For this purpose, a literature search was performed using the "PubMed" database. Publications older than ten years were excluded from this review. The literature search employed the keyword "chylothorax". The priority was set on publications including a comparative assessment of treatment approaches. The authors relied on many years of clinical experience to critically analyse and evaluate the treatment options and the given recommendations.
The success rate of the conservative treatment methods ranges widely, depending on the underlying cause of the disease (3 - 90%). Non-invasive or semi-invasive procedures are successful in 50 to 100% of the cases, also depending on the aetiology. After unsuccessful conservative treatment of operable patients, the standard surgical therapy consists of thoracic duct ligature, which is usually performed thoracoscopically. Alternatively, pleurodesis or the placement of a permanent chest drain (PleurX) or a pleuroperitoneal shunt may be performed. The success rate of these procedures is between 64 and 100%. The morbidity and mortality rate can reach values up to 25%.
Treatment of a chylothorax should be started conservatively. Subsequently, a more aggressive therapy may be gradually considered, based on the patient's health and the amount of the secretion. Interventional radiological procedures are safe, successful, and have a legitimate place alongside conservative or surgical treatment. However, they are currently only available in some larger centres.
乳糜胸是一种多因素并发症,通常由手术或创伤性损伤引起,较少由恶性疾病导致。由于缺乏前瞻性随机试验,循证治疗基于个人经验,但理想情况下应考虑回顾性分析。
本综述的目的是全面概述当前可用的现代治疗选择。另一个方面是展示它们的优缺点。为此,使用“PubMed”数据库进行了文献检索。超过十年的出版物被排除在本综述之外。文献检索采用关键词“乳糜胸”。重点是包括治疗方法比较评估的出版物。作者依靠多年的临床经验对治疗选择和给定建议进行批判性分析和评估。
保守治疗方法的成功率差异很大,取决于疾病的潜在病因(3%-90%)。非侵入性或半侵入性手术在50%至100%的病例中成功,同样取决于病因。对于可手术患者保守治疗失败后,标准手术治疗包括胸导管结扎,通常通过胸腔镜进行。或者,可以进行胸膜固定术或放置永久性胸腔引流管(PleurX)或胸膜腹膜分流术。这些手术的成功率在64%至100%之间。发病率和死亡率可高达25%。
乳糜胸的治疗应首先采用保守治疗。随后,可根据患者的健康状况和分泌量逐渐考虑更积极的治疗。介入放射学手术安全、成功,在保守或手术治疗中占有合理地位。然而,它们目前仅在一些较大的中心可用。